CSS LLC’s Astria Therapeutics ATXS Stock Holding History

CSS LLC’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,500	Closed	-$26K	–	1075
2021 Q1	$26K	Buy	1,500 +433	+41%	+$7.82K	﹤0.01%	885
2020 Q4	$14K	Buy	+1,067	New	+$19K	﹤0.01%	787

CSS LLC's ATXS Position: Q1 2026 in Review

CSS LLC sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 67,422 shares — an estimated $883K sold.

CSS LLC first reported a position in ATXS in Q4 2020 and held it in 3 quarters. The position peaked at $883K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

CSS LLC reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
CSS LLC sold 67,422 Astria Therapeutics shares in Q1 2026, an estimated $883K.
CSS LLC first reported a position in Astria Therapeutics in Q4 2020 and held it in 3 quarters.
CSS LLC's Astria Therapeutics position peaked at $883K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.